2026 Q3 Portfolio Activity
In 2026 Q3, First Turn Management, LLC maintained a portfolio of 44 distinct positions. The most significant new addition was GUARDANT HEALTH INC, now representing 5.19% of the total fund value. They heavily accumulated shares in KYMERA THERAPEUTICS INC, increasing the position by 10.5%. The fund also reduced its exposure to REVOLUTION MEDICINES INC by 77.8%.
Position History
hover any row below to update
Loading…
Total Positions
44
Quarter
2026 Q3
Top Holding
ELVN (5.8%)
Top 10 Concentration
43.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-44 of 44
First Turn Management, LLC Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 5.84% | 5.18% |
#1
3
Prev: #4
|
4.8 |
—
|
4,340 | 0.5% |
P
S
|
958,700 | $43,946,808 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GH
GUARDANT HEALTH...
|
Healthcare | 5.19% | — |
#2
Prev: #—
|
7.1 |
—
|
219,304 | — |
NEW
|
219,304 | $39,115,061 | 2025 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ABVX
ABIVAX SA
|
Healthcare | 5.06% | 6.98% |
#3
1
Prev: #2
|
3.0 |
—
|
-105,297 | -21.5% |
P
S
|
384,592 | $38,082,300 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ROIV
ROIVANT SCIENCE...
|
Healthcare | 4.79% | 5.04% |
#4
2
Prev: #6
|
2.4 |
—
|
-345,483 | -26.0% |
P
S
|
985,583 | $36,042,770 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 4.32% | 4.92% |
#5
2
Prev: #7
|
2.2 |
—
|
-24,868 | -29.3% |
P
S
|
60,064 | $32,548,081 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
VRDN
VIRIDIAN THERAP...
|
Healthcare | 4.17% | 3.28% |
#6
5
Prev: #11
|
2.2 |
—
|
-144,780 | -8.7% |
P
S
|
1,525,220 | $31,404,280 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 3.98% | 5.72% |
#7
4
Prev: #3
|
1.6 |
—
|
-56,008 | -25.6% |
P
S
|
162,407 | $29,946,227 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INSM
INSMED INC
|
Healthcare | 3.72% | 3.01% |
#8
4
Prev: #12
|
2.0 |
—
|
-18,125 | -6.9% |
P
S
|
245,726 | $28,047,166 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CELC
CELCUITY INC
|
Healthcare | 3.48% | 3.68% |
#9
1
Prev: #10
|
2.4 |
—
|
no change | no change |
P
S
|
329,101 | $26,170,112 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CRL
CHARLES RIV LAB...
|
Healthcare | 3.40% | — |
#10
Prev: #—
|
4.9 |
—
|
86,801 | — |
NEW
|
86,801 | $25,607,163 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 3.13% | 4.81% |
#11
3
Prev: #8
|
1.3 |
—
|
-169,467 | -32.1% |
P
S
|
357,945 | $23,592,155 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 3.10% | 5.05% |
#12
7
Prev: #5
|
1.2 |
—
|
-278,993 | -44.0% |
P
S
|
354,371 | $23,317,612 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PRAX
PRAXIS PRECISIO...
|
Healthcare | 3.05% | 2.99% |
#13
2
Prev: #15
|
1.7 |
—
|
-4,722 | -5.7% |
P
S
|
78,806 | $22,950,671 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 2.82% | 2.34% |
#14
8
Prev: #22
|
1.1 |
—
|
-442,950 | -22.0% |
P
S
|
1,574,334 | $21,206,279 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RGEN
REPLIGEN CORP
|
Healthcare | 2.77% | — |
#15
Prev: #—
|
4.6 |
—
|
108,436 | — |
NEW
|
108,436 | $20,844,652 | 2024 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
TNGX
TANGO THERAPEUT...
|
Healthcare | 2.54% | — |
#16
Prev: #—
|
4.5 |
—
|
766,860 | — |
NEW
|
766,860 | $19,133,157 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 2.52% | 8.32% |
#17
16
Prev: #1
|
1.0 |
—
|
-322,991 | -77.8% |
P
S
|
92,316 | $18,948,782 | 2024 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
INBX
INHIBRX BIOSCIE...
|
Healthcare | 2.28% | 1.67% |
#18
8
Prev: #26
|
1.4 |
—
|
6,729 | 4.1% |
P
S
|
171,512 | $17,164,921 | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 2.27% | 2.11% |
#19
4
Prev: #23
|
3.4 |
—
|
119,899 | 20.6% |
P
S
|
702,396 | $17,082,271 | 2025 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MANE
VERADERMICS INC
|
Healthcare | 2.20% | — |
#20
Prev: #—
|
4.4 |
—
|
136,718 | — |
NEW
|
136,718 | $16,574,323 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 2.19% | 2.49% |
#21
1
Prev: #20
|
1.4 |
—
|
-87,305 | -14.5% |
P
S
|
514,976 | $16,489,532 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 2.09% | 2.98% |
#22
6
Prev: #16
|
0.8 |
—
|
-107,198 | -37.5% |
P
S
|
178,573 | $15,723,353 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 2.01% | 2.56% |
#23
4
Prev: #19
|
0.8 |
—
|
-46,579 | -29.8% |
P
S
|
109,871 | $15,154,507 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.99% | 1.83% |
#24
1
Prev: #25
|
1.3 |
—
|
3,585 | 2.3% |
P
S
|
157,603 | $15,006,170 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
RCUS
ARCUS BIOSCIENC...
|
Healthcare | 1.98% | — |
#25
Prev: #—
|
4.3 |
—
|
577,693 | — |
NEW
|
577,693 | $14,921,810 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 1.94% | — |
#26
Prev: #—
|
4.3 |
—
|
222,649 | — |
NEW
|
222,649 | $14,572,377 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
IRON
DISC MEDICINE I...
|
Healthcare | 1.92% | — |
#27
Prev: #—
|
4.3 |
—
|
220,666 | — |
NEW
|
220,666 | $14,444,796 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ERAS
ERASCA INC
|
Healthcare | 1.78% | 2.39% |
#28
7
Prev: #21
|
0.7 |
—
|
-308,269 | -25.2% |
P
S
|
913,452 | $13,391,206 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
GRAL
GRAIL INC
|
Healthcare | 1.74% | — |
#29
Prev: #—
|
4.2 |
—
|
93,727 | — |
NEW
|
93,727 | $13,133,027 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 1.68% | 1.26% |
#30
1
Prev: #29
|
2.7 |
—
|
10,766 | 10.5% |
P
S
|
113,299 | $12,665,695 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 1.65% | 2.99% |
#31
17
Prev: #14
|
0.7 |
—
|
-50,283 | -47.9% |
P
S
|
54,594 | $12,438,151 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
QURE
UNIQURE NV
|
Healthcare | 1.49% | 3.00% |
#32
19
Prev: #13
|
0.6 |
—
|
-143,451 | -23.6% |
P
S
|
465,474 | $11,245,852 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
XENE
XENON PHARMACEU...
|
Healthcare | 1.47% | 3.88% |
#33
24
Prev: #9
|
0.6 |
—
|
-303,140 | -50.5% |
P
S
|
297,060 | $11,047,661 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SYRE
SPYRE THERAPEUT...
|
Healthcare | 1.21% | — |
#34
Prev: #—
|
4.0 |
—
|
102,541 | — |
NEW
|
102,541 | $9,129,225 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SMMT
SUMMIT THERAPEU...
|
Healthcare | 1.13% | — |
#35
Prev: #—
|
4.0 |
—
|
501,724 | — |
NEW
|
501,724 | $8,484,153 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 1.09% | — |
#36
Prev: #—
|
3.9 |
—
|
216,531 | — |
NEW
|
216,531 | $8,241,170 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
PCVX
VAXCYTE INC
|
Healthcare | 1.04% | 2.76% |
#37
20
Prev: #17
|
0.4 |
—
|
-306,302 | -69.0% |
P
S
|
137,534 | $7,825,685 | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
HNGE
HINGE HEALTH IN...
|
Healthcare | 0.97% | — |
#38
Prev: #—
|
3.9 |
—
|
75,448 | — |
NEW
|
75,448 | $7,336,564 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
NUVL
NUVALENT INC
|
Healthcare | 0.00% | 0.35% |
Sold All 😨
(Was: #31) |
0.0 |
—
|
-26,298 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SION
SIONNA THERAPEU...
|
Healthcare | 0.00% | 0.52% |
Sold All 😨
(Was: #30) |
0.0 |
—
|
-110,493 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
ORKA
ORUKA THERAPEUT...
|
Healthcare | 0.00% | 1.58% |
Sold All 😨
(Was: #28) |
0.0 |
—
|
-155,343 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
SRRK
SCHOLAR ROCK HL...
|
Healthcare | 0.00% | 1.60% |
Sold All 😨
(Was: #27) |
0.0 |
—
|
-271,227 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
APGE
APOGEE THERAPEU...
|
Healthcare | 0.00% | 1.97% |
Sold All 😨
(Was: #24) |
0.0 |
—
|
-138,822 | -100.0% |
CLOSED
|
— | $— | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-16 | |||
|
MIRM
MIRUM PHARMACEU...
|
Healthcare | 0.00% | 2.73% |
Sold All 😨
(Was: #18) |
0.0 |
—
|
-218,051 | -100.0% |
CLOSED
|
— | $— | 2023 Q4 | 13F Filing | 2026-09-30 | 2026-11-16 |
Showing 1-44 of 44 holdings